MoonLake Immunotherapeutics
Zug
About MoonLake Immunotherapeutics
MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company crating novel therapies, and unlocking the potential of Sonelokimab, the novel investigational Nanobody® for the treatment of inflammation, to revolutionize outcomes for patients.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Total funding: $665.0M
- Funding stage: IPO
- Last round: Post-IPO Equity (Nov 2025)
- Ticker: nasdaq:MLTX
- Website: moonlaketx.com
- Phone: +41 415108022
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/moonlake-immunotherapeutics-111883 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.